Preparation for substitution therapy, containing at least one progestogen and at least one estrogen
Patent 5827843 Issued on October 27, 1998. Estimated Expiration Date: 
June 4, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
June 4, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorAssigneeApplicationNo. 605118 filed on 06/04/1996US Classes:514/170Plural Compounds containing cyclopentanohydrophenanthrene ring systemsExaminersPrimary: Fay, ZohrehAttorney, Agent or FirmForeign Patent References
International ClassA61K 031/56Foreign Application Priority Data1993-09-09 NLAbstractThe invention relates to a preparation for substitution therapy and oral contraception comprising at least one progestogen and at least one estrogen in which the estrogen dose varies with a periodicity such that blood loss is substantially avoided, wherein the periodicity is preferably less than 10 days, more preferably less than 7 days, such as preparations containing the progestogen and/or estrogen in an oral, transdermal, parenteral and/or implantable application form. | |
